Search research articles
Contact Us
Filters
Showing results (251-260 of 267) with videos related to
Page
of 27
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 19, 2022
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)
Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, et al.
The Lancet. HIV
|
May 13, 2024
Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial
Serge P Eholie, Didier K Ekouevi, Corine Chazallon, et al.
Infectious Diseases and Therapy
|
June 29, 2022
Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic
E Ariza-Vioque, F Ello, H Andriamamonjisoa, et al.
The Lancet. HIV
|
October 12, 2019
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study
Serge P Eholie, Raoul Moh, Aïda Benalycherif, et al.
Blood
|
September 22, 2005
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy
Thierry Facon, Jean-Yves Mary, Brigitte Pégourie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2017
ABVD or BEACOPP<sub>baseline</sub> along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial
Christophe Fermé, José Thomas, Pauline Brice, et al.
Journal of the Pediatric Infectious Diseases Society
|
August 21, 2024
Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE)
Alexandre Duvignaud, Ijeoma C Etafo, Marie Jaspard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 3, 2016
Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days
Boubacar Diallo, Daouda Sissoko, Nicholas J Loman, et al.
Haematologica
|
October 6, 2018
Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes
Sophie Park, Olivier Kosmider, Frédéric Maloisel, et al.
Travel Medicine and Infectious Disease
|
January 25, 2020
Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE)
Alexandre Duvignaud, Marie Jaspard, Ijeoma Chukwudumebi Etafo, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 267) with videos related to
Sort By:
Page
of 27
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 19, 2022
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)
Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, et al.
The Lancet. HIV
|
May 13, 2024
Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial
Serge P Eholie, Didier K Ekouevi, Corine Chazallon, et al.
Infectious Diseases and Therapy
|
June 29, 2022
Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic
E Ariza-Vioque, F Ello, H Andriamamonjisoa, et al.
The Lancet. HIV
|
October 12, 2019
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study
Serge P Eholie, Raoul Moh, Aïda Benalycherif, et al.
Blood
|
September 22, 2005
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy
Thierry Facon, Jean-Yves Mary, Brigitte Pégourie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2017
ABVD or BEACOPP<sub>baseline</sub> along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial
Christophe Fermé, José Thomas, Pauline Brice, et al.
Journal of the Pediatric Infectious Diseases Society
|
August 21, 2024
Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE)
Alexandre Duvignaud, Ijeoma C Etafo, Marie Jaspard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 3, 2016
Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days
Boubacar Diallo, Daouda Sissoko, Nicholas J Loman, et al.
Haematologica
|
October 6, 2018
Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes
Sophie Park, Olivier Kosmider, Frédéric Maloisel, et al.
Travel Medicine and Infectious Disease
|
January 25, 2020
Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE)
Alexandre Duvignaud, Marie Jaspard, Ijeoma Chukwudumebi Etafo, et al.
Page
of 27